AnaMar Medical Raises $7.3 Million

AnaMar Medical AB, a Sweden-based drug developer whose first candidate focuses on rheumatoid arthritis, has raised SEK 57.5 million (US$7.3m) in new VC funding from existing backers Koncentra Holding and LinkMed. www.anamar.com